In the News
Could Revolutionary Gene-editing Technology End Cancer?
CRISPR, a revolutionary technology that can edit genetic mistakes, is getting attention and scrutiny. It could help get rid of diseases like cystic fibrosis, muscular dystrophy and even HIV and cancer.
The New York Times: The Crispr Quandary
A new gene-editing tool might create an ethical morass — or it might make revising nature seem natural.
QB3: Caribou Named the Winner of the Groundbreaking Science Award at the 2015 QB3 Awards
The QB3 Awards were created to recognize the highest level of achievement in life science entrepreneurship in the San Francisco Bay Area.
Genome Web: DuPont, Caribou Biosciences Ink Strategic Alliance on CRISPR, Cross-License IP
DuPont and Caribou Biosciences today announced a strategic alliance focused on agricultural applications of CRISPR/Cas9 genome editing.
Xconomy: West Coast Biotech Roundup: Caribou, Amgen, CytomX, Arena & More
We were stuck for a couple days in a Nobel vortex. Speculation about a Nobel Prize in chemistry for University of California, Berkeley scientist Jennifer Doudna and her gene-editing research partner, Emmanuelle Charpentier, swirled and swirled until everyone following it got a bit dizzy.